AzTrials
AzTrials

Alcohol Use DisordersNCT02272023

Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women

A study testing Intensive Motivational Interviewing and Single session of Motivational Interviewing in people with Alcohol Use Disorders, run by Public Health Institute, California at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A Phase II Randomized Clinical Trial (RCT) is proposed to compare a 9-session model of intensive motivational interviewing (IMI) to standard motivational interviewing techniques (SMI) among alcohol dependent women. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Alcohol Use Disorders
What is being tested?
Intensive Motivational Interviewing and Single session of Motivational Interviewing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
215 participants
Where
1 siteUnited States
Study dates
Feb 2015to 7 Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 1) Female 2)18 years or older 3) meets DSM-V criteria for current alcohol use disorder in the past 30 days, as assessed by the DSM-V Checklist, defined as 2 or more criterion 4) alcohol in the past 30 days and medically cleared by NLTC medical personnel 5) able to speak and read English, 6) capable of giving informed consent 7) likely to be in the area the next 12 months.

Who cannot join

  • has had alcohol in the past 3 days and may require medical treatment for alcohol or drug detoxification and is not followed by a physician or has not been medically cleared by NLTC medical personnel
  • or has unmet needs for treatment of serious medical or psychiatric conditions
  • any condition that would impair their ability to provide informed consent
  • current severe drug use disorder, defined as 6 or more DSM-V criteria in the past 30 days, 5.)Currently enrolled in alcohol or drug treatment
  • 6) Does not meet DSM-V criteria for current alcohol use disorder as assessed by the DSM-V Checklist, 7) Refuses to sign HIPPA authorization form 8) Any medical or psychosocial condition that would preclude safe, useful, or consistent participation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • New Leaf Treatment Center

    Lafayette, California, 94549

Other trials in United States

About this study

A Phase II Randomized Clinical Trial (RCT) is proposed to compare a 9-session model of intensive motivational interviewing (IMI) to standard motivational interviewing techniques (SMI) among alcohol dependent women. Preliminary work studying 87 women randomly assigned to IMI or a standard single session of motivational interviewing showed significantly better drinking outcomes for women in the IMI condition at 4- and 6-month follow-up. Interestingly, mean trajectories for women assigned to IMI showed continuing declines in drinking problems during and after treatment. Differences between study conditions grew larger between 4-month (p<.05) and 6-month (p<.01) follow-up and the effect size at 6 months was medium to large (Cohen's d=0.63) The study will use mixed model quantitative and qualitative methods to respond to the PA's call for studies assessing mechanisms of change. Unlike many previous studies of SMI, we will employ limited exclusion criteria and will enroll participants who present with co-existing drug and psychiatric disorders.

Procedures for the proposed study draw from our current successful RCT assessing IMI for methamphetamine (MA) dependence. Successful aspects of the current study include achievement of recruitment goals, strong adherence to the treatment and research protocols, and excellent rates for follow-up interviews (>90%). The proposed study will take place at the same outpatient treatment program as the current study, New Leaf Treatment Center in Lafayette, California.

Participants will include 220 alcohol dependent women who will be randomly assigned to IMI or SMI. Those in SMI will also receive an attention component (nutrition education) to achieve time equivalence between the two study conditions. Participants in both groups will receive standard weekly group treatment offered at the program. In addition, referrals to Alcoholics Anonymous will be provided to all participants. The primary outcomes will be measures of drinking, heavy drinking (4+ drinks), and severity of alcohol problems assessed at baseline and 2, 6, and 12 months. Secondary outcomes will include Addiction Severity Index scales, psychiatric problems, and symptoms of trauma. The study will include standard quantitative testing of potential mediators, including, the therapeutic alliance, self-efficacy, motivation, satisfaction, and use of outside services. However, the application also proposes an innovative use of qualitative procedures to identify unrecognized factors influencing outcome.

Read the detailed description

The proposed study responds to the Program Announcement PA-10-100, "Alcohol Use Disorders: Treatment, Services Research, and Recovery" (R01) issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Our application addresses the priorities of this announcement by proposing a phase II randomized clinical trial comparing intensive motivational interviewing (IMI) to standard motivational interviewing techniques (SMI) for alcohol dependent women. The study will use mixed model quantitative and qualitative methods to respond to the program announcement's call for studies assessing mechanisms of change. Unlike many previous studies of SMI we will employ limited exclusion criteria and will enroll participants who present with co-existing drug and psychiatric disorders.

SMI was initially developed as a brief intervention (typically 1-3 sessions) for the treatment of problem drinkers (Miller \& Rollnick, 2002). The general strategy of SMI is to strategically combine supportive and directive interventions as a way to elicit ambivalence about substance use (i.e., pros and cons) and thereby increase motivation for change. Systematic reviews of the alcohol treatment literature have consistently shown SMI to be effective for treating alcohol use disorders (Hettema, Steele, \& Miller, 2005; Dunn, Deroo, Rivera, 2001). Studies have shown SMI to be effective as a stand-alone treatment for alcohol problems (Project MATCH Research Group, 1997; Miller, 1993; Sellman, Sullivan, Dore, Adamson, \& MacEwan, 2001) and as preparation for more intensive treatment (Burke, Arkowitz, \& Menchola, 2003). Perhaps the best-known and largest study of an SMI based was an assessment of "motivational enhancement therapy" (MET) as a stand-alone, 4 session condition conducted by the Project MATCH Research Group (Sellman, Sullivan, Dore, Adamson, \& MacEwan, 2001; Project MATCH Research Group, 1998). Participants were randomly assigned to 4 sessions of MET, 12 sessions of cognitive behavioral counseling (CBT), or 12 sessions of 12-step facilitation (TSF). Despite fewer sessions in MET, outcomes among the 3 conditions were comparable. A limitation of the study was that individuals with serious co-occurring drug or mental health problems were excluded as were those with housing instability.

Like Project MATCH, most studies of SMI for alcohol problems have excluded participants who have serious co-occurring drug and mental health problems. However, these are precisely the types of individuals that treatment practitioners are likely to encounter in publicly funded treatment programs. When SMI interventions have targeted illicit drug dependence the results have been mixed. While a number of reviews (Dunn, Deroo, Rivera, 2001) and meta-analyses (Burke, Arkowitz, \& Menchola, 2003; Hettema, Steele, \& Miller, 2005) have concluded standard low-dose SMI is effective as preparation for more intensive drug treatment, some studies contradict these findings (Downey, Rosengren, \& Donovan, 2001; Miller, Yahne, Tonigan, 2003; Winhusen et al., 2008; Mullins, Suerez, Ondersman, Page, 2004; Schneider, Casey, Kohn, 2000). When effects have been found for drug and co-occurring disorders they have most commonly been for retention, not substance use (Carroll et al., 2006).

Procedures for the proposed study draw from our current successful RCT assessing IMI for MA dependence. Successful aspects of the current study include achievement of recruitment goals, strong adherence to the treatment and research protocols, and excellent rates for follow-up interviews (>90%). The proposed study will take place at the same outpatient treatment program as the current study, New Leaf Treatment Center in Lafayette, California. Two hundred and twenty alcohol dependent women will be randomly assigned to IMI or SMI with an attention component for time equivalence (nutrition education). Participants in both groups will receive standard group treatment offered at the program. The primary outcomes will be measures of drinking, heavy drinking (4+ drinks), and severity of alcohol problems assessed at baseline and 2, 6, and 12 months. Secondary outcomes will include Addiction Severity Index scales, psychiatric problems, and symptoms of trauma. The study will include standard quantitative testing of potential mediators, including, the therapeutic alliance, self-efficacy, motivation, satisfaction, and use of outside services. However, the application also proposes an innovative use of qualitative procedures to identify unrecognized factors influencing outcome.

Aim 1: To compare drinking and alcohol problems among women receiving IMI and SMI.

Hypothesis 1.1: During the active phase of treatment (weeks 1-9) women in IMI will have fewer positive breathalyzer screens, drinking days, and heavy drinking days (4+ drinks) than women in SMI.

Hypothesis 1.2: Women in IMI will demonstrate fewer drinking days and heavy drinking days (4+ drinks) and lower scores on the Addiction Severity Index (ASI) Alcohol Scale at 2, 6, and 12 months.

Aim 2: To assess potential mediators of drinking and alcohol problems. Hypothesis 2.1: Measures of retention, therapeutic alliance, social support, and motivation will mediate the relationship between study condition and drinking outcome.

Aim 3: To Use qualitative interviews to identify additional factors that influence outcome. Content areas will include perceptions of the therapist, IMI \& SMI interventions, the CBT group, and external influences such as Alcoholics Anonymous (AA), intimate partners, friends, and family.

Exploratory Aims: 1) To compare IMI and SMI outcomes on ASI scales, psychiatric symptoms, AA involvement, and trauma symptoms.

Being tested
Intensive Motivational Interviewing, Single session of Motivational Interviewing
Keywords
alcohol, women, motivational interviewing
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intensive Motivational InterviewingBehavioural

    Weekly individual therapy sessions over 9 weeks (Intensive MI condition) consisting of supportive and directive interventions. The control condition consists on a single session of MI and nutritional education.

  • Single session of Motivational InterviewingBehavioural

Study groups in NCT02272023
Study groupRoleWhat they receive
9 sessions of Intensive Motivational InterviewingExperimentalExperimental condition will consist of 9 1-hour intensive motivational interviewing sessions.
Receives: Behavioral: Intensive Motivational Interviewing
1 Standard Motivational Interview plus 8 nutrition classesActive comparatorThe standard MI intervention will consist of a commonly used, single session of MI (50 minutes) plus 8 hours of nutrition education to achieve time and attention equivalence of study conditions.
Receives: Behavioral: Single session of Motivational Interviewing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the number of drinks and frequency of drinks in the past two months

    Change in daily drinking patterns (quantity and frequency) over the past two months using the Timeline follow-back assessment

    Measured: Baseline, 2 months, 6 months, and 12 months

  2. Change in the severity of alcohol use within past 30 days

    Change in alcohol Addiction Severity Index (ASI) scores in the past 30 days

    Measured: Baseline, 2 months, 6 months, and 12 months

Secondary outcomes (3)
  1. Change in employment, psychiatric status, and legal status over the past 30 days

    Change in employment, psychiatric status, and legal status over the past 30 days as assessed by the Addiction Severity Index (ASI)

    Measured: Baseline, 2 months, 6 months, and 12 months

  2. Change in mental health

    Change in emotions, moods, thoughts, and behaviors in the past two weeks as assessed by the Psychiatric Diagnostic Screening Questionnaire (PDSQ)

    Measured: Baseline, 2 months, 6 months, and 12 months

  3. Change in trauma and stress levels

    Change in drinking consequences scores as assessed by Alcohol and Drug Consequences Questionnaire (ADCQ)

    Measured: Baseline, 2 months, 6 months, and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2014 (estimated)
  2. Study startFeb 2015
  3. Primary completionMar 2019
  4. Study completion7 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
215 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02272023
Sponsor's protocol ID
R01AA022857
Status last verified
Sep 2019
First submitted
20 Oct 2014
Last updated
18 Sep 2019
Results posted
No
Data monitoring committee
No

Publications

  • Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003 Oct;71(5):843-61. doi: 10.1037/0022-006X.71.5.843.

    PubMed 14516234
  • Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, Kunkel LE, Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE; National Institute on Drug Abuse Clinical Trials Network. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006 Feb 28;81(3):301-12. doi: 10.1016/j.drugalcdep.2005.08.002. Epub 2005 Sep 28.

    PubMed 16169159
  • Downey L, Rosengren DB, Donovan DM. Sources of motivation for abstinence: a replication analysis of the reasons for quitting questionnaire. Addict Behav. 2001 Jan-Feb;26(1):79-89. doi: 10.1016/s0306-4603(00)00090-3.

    PubMed 11196294
  • Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001 Dec;96(12):1725-42. doi: 10.1046/j.1360-0443.2001.961217253.x.

    PubMed 11784466
  • Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91-111. doi: 10.1146/annurev.clinpsy.1.102803.143833.

    PubMed 17716083
  • Miller WR, Yahne CE, Tonigan JS. Motivational interviewing in drug abuse services: a randomized trial. J Consult Clin Psychol. 2003 Aug;71(4):754-63. doi: 10.1037/0022-006x.71.4.754.

    PubMed 12924680
  • Mullins SM, Suarez M, Ondersma SJ, Page MC. The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abuse Treat. 2004 Jul;27(1):51-8. doi: 10.1016/j.jsat.2004.03.010.

    PubMed 15223094
  • Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997 Jan;58(1):7-29.

    PubMed 8979210
  • Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998 Sep;22(6):1300-11. doi: 10.1111/j.1530-0277.1998.tb03912.x.

    PubMed 9756046
  • Schneider RJ, Casey J, Kohn R. Motivational versus confrontational interviewing: a comparison of substance abuse assessment practices at employee assistance programs. J Behav Health Serv Res. 2000 Feb;27(1):60-74. doi: 10.1007/BF02287804.

    PubMed 10695241
  • Sellman JD, Sullivan PF, Dore GM, Adamson SJ, MacEwan I. A randomized controlled trial of motivational enhancement therapy (MET) for mild to moderate alcohol dependence. J Stud Alcohol. 2001 May;62(3):389-96. doi: 10.15288/jsa.2001.62.389.

    PubMed 11414349
  • Winhusen T, Kropp F, Babcock D, Hague D, Erickson SJ, Renz C, Rau L, Lewis D, Leimberger J, Somoza E. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat. 2008 Sep;35(2):161-73. doi: 10.1016/j.jsat.2007.09.006. Epub 2008 Feb 20.

    PubMed 18083322
  • Miller WR. What really drives change? Addiction. 1993 Nov;88(11):1479-80. doi: 10.1111/j.1360-0443.1993.tb03133.x. No abstract available.

    PubMed 8286993

Questions about this trial

What is this clinical trial studying?

A study testing Intensive Motivational Interviewing and Single session of Motivational Interviewing in people with Alcohol Use Disorders, run by Public Health Institute, California at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the number of drinks and frequency of drinks in the past two months (time frame: Baseline, 2 months, 6 months, and 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02272023, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in